RE:RE:RE:RE:FSD PHarma Q&A - Text Copy pasteYou are right. Aurora is 18x its asset and 12x the revenue, to me that is overvalued when the operating expense around 120m. Dried cannabis with mold seem very frequent now. They need to find a better way to deliver the product that maintain the quality. Most people invest for growth, there is nothing wrong with speculating and analyze the market. Everyone always speculate for the under value company. I speculate when I buy shoes, car, house, jacket, suits, anything.
The building XLY invest it will be shown in FSD financial statement when the construction is finished. That will bring the asset up to $150m which is 1/3 of current marketcap. It is much less than most company. Other companies that I think are undervalued based on asset JWCA and supreme 2x the asset. Banks use asset as collateral, and if recession is coming I wanna find companies that has the least gap between market value and their tangible asset.
Fsd so far understand supply chain management and put other company PILL under the same facility. I don't think they need to spend more money on logistic which will bring the market price higher.
Acquiring therapix was a good move as well, since old players know R&D to patent can take longer than license. Getting something half baked for $50m is time saving.
I am not too obsessed with retail because it is brick to mortar. I can see cannabis in vending machine that has security just like the automated custom at the airport. Budtender is very vague and sounds like old car salesman. I like to check what product to buy online. You can't tell it is a good product until you consume it.
I used to owned land and built houses which was financed by the contractor. Any risk for quality, cost, and time will be taken by him. I didn't mind because I can focus at other aspect of the business. We split the profit accordingly. It is not about gaining profit but when the project is big, smart investor mitigate any risk involved. Pyramid business model acquiring everything can be costly and make the company inefficient. Jv has benefit, it is a mutual relationship at low cost and low default risk. It keeps the business ecosystem alive. Focus is the strength of FSD.
If the stock goes lower I'll just buy more every 50-60% lost. I'm sitting on cash so I am not worry. Actually, I'm hoping it crashed like Namaste back in 2015 to 0.008 which mostly intangible assets. If you are investing in this stock please diversify to other mature cannabis company as well that generate revenue already and have lean expenses (exp<rev).
I don't waste my time replying on negativity, unless they did their homework and not acting like a highschool kid. I'm gonna check this forum less frequent and let the bashers talk to themselves.